Benzinga's Top Pre-Market Gainers
Supernus Pharmaceuticals (NASDAQ: SUPN) surged 26.09% to $7.20 in the pre-market session. Supernus Pharmaceuticals received a tentative approval letter from the FDA for Trokendi XR(TM).
News Corp (NASDAQ: NWSA) added 5.05% to $21.10 in the pre-market session. News Corp is reportedly considering splitting into two companies.
Arena Pharmaceuticals (NASDAQ: ARNA) moved up 4.40% to $9.60 in the pre-market session. Arena Pharmaceuticals shares have jumped 586.57% over the past 52 weeks, while the S&P 500 index has gained 1.31% in the same period..
Apollo Group (NASDAQ: APOL) soared 3.94% to $33.75 in the pre-market trading. Apollo Group reported better-than-expected FQ3 profit.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.